11/20
12:33 pm
akro
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
Low
Report
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
11/18
12:20 pm
akro
Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights
11/12
01:55 pm
akro
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
11/12
01:22 pm
akro
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
Low
Report
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
11/10
06:41 pm
akro
Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]
Low
Report
Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]
11/10
12:59 pm
akro
Hepta Unveils First Multi-Omic Atlas of MASH, Linking Liver Pathway Biology to cfDNA Methylation in Blood [Yahoo! Finance]
Low
Report
Hepta Unveils First Multi-Omic Atlas of MASH, Linking Liver Pathway Biology to cfDNA Methylation in Blood [Yahoo! Finance]
11/7
07:00 am
akro
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
Low
Report
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
11/5
11:45 am
akro
Halper Sadeh LLC Encourages AKRO, CADE, FSUN Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages AKRO, CADE, FSUN Shareholders to Contact the Firm to Discuss Their Rights
11/4
04:41 pm
akro
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
Low
Report
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
10/29
06:06 pm
akro
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
Low
Report
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
10/29
09:06 am
akro
Halper Sadeh LLC Encourages FFWM, AKRO, CCRD Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages FFWM, AKRO, CCRD Shareholders to Contact the Firm to Discuss Their Rights
10/22
10:41 am
akro
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
10/19
11:28 am
akro
Assessing Akero Therapeutics (AKRO) Valuation After Strong Share Price Gains [Yahoo! Finance]
Low
Report
Assessing Akero Therapeutics (AKRO) Valuation After Strong Share Price Gains [Yahoo! Finance]
10/16
04:51 pm
akro
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
10/14
12:50 pm
akro
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders
Low
Report
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders
10/11
06:14 am
akro
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at HC Wainwright from a "strong-buy" rating to a "hold" rating.
Low
Report
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at HC Wainwright from a "strong-buy" rating to a "hold" rating.
10/11
06:14 am
akro
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at Lifesci Capital from a "strong-buy" rating to a "hold" rating.
Low
Report
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at Lifesci Capital from a "strong-buy" rating to a "hold" rating.
10/11
01:10 am
akro
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at
Wall Stre
Low
Report
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at
Wall Stre
10/10
06:14 pm
akro
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
Low
Report
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
10/10
05:30 pm
akro
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)
10/10
08:06 am
akro
Akero Therapeutics (NASDAQ:AKRO) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
Akero Therapeutics (NASDAQ:AKRO) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
10/10
07:31 am
akro
Akero: Novartis Acquisition Puts Focus On Unprecedented MASH Data With EFX [Seeking Alpha]
Neutral
Report
Akero: Novartis Acquisition Puts Focus On Unprecedented MASH Data With EFX [Seeking Alpha]
10/10
07:19 am
akro
Akero Therapeutics (NASDAQ:AKRO) was given a new $54.00 price target on by analysts at HC Wainwright.
Low
Report
Akero Therapeutics (NASDAQ:AKRO) was given a new $54.00 price target on by analysts at HC Wainwright.
10/9
10:59 pm
akro
Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger [Yahoo! Finance]
Low
Report
Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger [Yahoo! Finance]
10/9
12:21 pm
akro
Akero Therapeutics (NASDAQ:AKRO) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $56.00 price target on the stock, down previously from $75.00.
Low
Report
Akero Therapeutics (NASDAQ:AKRO) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $56.00 price target on the stock, down previously from $75.00.